跳至主要内容
临床试验/JPRN-UMIN000044808
JPRN-UMIN000044808已完成未知

The effect of the milk drink on immunity index for healthy adults: A double-blind, randomized, controlled parallel group study - The effect of the milk drink on immunity index for healthy adults: A double-blind, randomized, controlled parallel group study

CPCC Company Limited0 个研究点目标入组 12 人开始时间: 2021年7月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 50years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1. Subjects who tested positive for SARS-CoV-2 before the screening, who tested positive for hepatitis B virus, hepatitis C virus, syphilis and human immunodeficiency virus in the screening. 2. Subjects who themselves or family living together tested positive for SARS-CoV-2, or have a fever of 37.5 degrees or higher within the last four weeks. 3. Subjects who are planning to receive the COVID-19 vaccine during the trial. 4. Subjects who have diseases which are difficult to differentiate from upper respiratory infection by themselves. 5. Subjects who have abdominal symptoms by ingesting dairy products. 6. Subjects who constantly intake fermented dairy products and/or lactic acid bacteria preparation. 7. Subjects who constantly use food for specified health use, functional foods, supplements, and/or healthy food having a possibility of affecting the result of this trial. 8. Subjects who have previous and/or current medical history of serious disease. 9. Subjects who with heavy use of alcohol, and heavy smoking. 10. Subjects who have extremely irregular dining habits. 11. Subjects who are participating the other clinical tests, who participated the other clinical tests within 4-weeks prior to the current study. 12. Subjects who have previous medical history of drug and/or food, allergy, especially for milk. 13. Subjects who donated over 200mL blood and/or blood components within the last one month. 14. Subjects who donated over 400mL blood and/or blood components within the last three month. 15. Subjects who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 16. Others who have been determined ineligible by principal investigator.

研究者

发起方
CPCC Company Limited

相似试验